Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

Golda S. Ginsburg; Anne Marie Albano; Robert L. Findling; Christopher Kratochvil; John Walkup

doi:10.1016/S1077-7229(05)80030-6

Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

Golda S. Ginsburg, Anne Marie Albano, Robert L. Findling, Christopher Kratochvil, John Walkup

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

Original language	English (US)
Pages (from-to)	252-262
Number of pages	11
Journal	Cognitive and Behavioral Practice
Volume	12
Issue number	2
DOIs	https://doi.org/10.1016/S1077-7229(05)80030-6
State	Published - 2005

ASJC Scopus subject areas

Clinical Psychology

Access to Document

10.1016/S1077-7229(05)80030-6

Cite this

@article{c90cea4508534ca683532b107e07f8ba,

title = "Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression",

abstract = "Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing {"}dosage{"} and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.",

author = "Ginsburg, {Golda S.} and Albano, {Anne Marie} and Findling, {Robert L.} and Christopher Kratochvil and John Walkup",

year = "2005",

doi = "10.1016/S1077-7229(05)80030-6",

language = "English (US)",

volume = "12",

pages = "252--262",

journal = "Cognitive and Behavioral Practice",

issn = "1077-7229",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

AU - Ginsburg, Golda S.

AU - Albano, Anne Marie

AU - Findling, Robert L.

AU - Kratochvil, Christopher

AU - Walkup, John

PY - 2005

Y1 - 2005

N2 - Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

AB - Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

UR - http://www.scopus.com/inward/record.url?scp=32444436277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32444436277&partnerID=8YFLogxK

U2 - 10.1016/S1077-7229(05)80030-6

DO - 10.1016/S1077-7229(05)80030-6

M3 - Article

AN - SCOPUS:32444436277

SN - 1077-7229

VL - 12

SP - 252

EP - 262

JO - Cognitive and Behavioral Practice

JF - Cognitive and Behavioral Practice

IS - 2

ER -

Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this